Know Cancer

or
forgot password


Phase 2
18 Years
N/A
Not Enrolling
Both
Lymphoma, Non-Hodgkin

Thank you

Trial Information

Inclusion Criteria


Inclusion:

- Diagnosis: CD20+ B-cell non-Hodgkin's lymphoma (NHL) classified as intermediate- or
high-grade according to the Working Formulation, subtypes D to H. Must have
measureable progressive or refractory disease after no more than three prior
chemotherapy regimens.

Exclusion:

- Clinically significant cardiac dysfunction, or a history of myocardial infarction or
heart failure within 6 months of first study treatment

- Clinically significant pulmonary dysfunction.

- Liver disease (note hepatitis C seropositive subjects may be enrolled if they have no
active disease as demonstrated by undetectable HCV viral loads, biopsy showing no
active disease, and/or history of normal transaminases on at least three different
dates within one year of first study treatment).

- Symptomatic thyroid disease requiring medical intervention other than replacement
treatment for hypothyroidism.

- History of autoimmune disease.

- History of positive serology for human immunodeficiency virus (HIV).

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

IL2NHL05

NCT ID:

NCT00045864

Start Date:

Completion Date:

Related Keywords:

  • Lymphoma, Non-Hodgkin
  • Intermediate and High-Grade Non-Hodgkin's Lymphoma
  • Lymphoma
  • Lymphoma, Non-Hodgkin

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021
Stanford University Medical CenterStanford, California  94305-5408
John Wayne Cancer InstituteSanta Monica, California  90404
Cancer Centers of the CarolinasGreenville, South Carolina  29605
Rush Cancer InstituteChicago, Illinois  60612
Vanderbilt University Medical CenterNashville, Tennessee  37232-2516
Washington Cancer InstituteWashington, District of Columbia  20010
Cancer Care CenterNew Albany, Indiana  47150
Consultants in Blood Disorders and CancerLouisville, Kentucky  40207
University of PennsylvaniaPhiladelphia, Pennsylvania  19104
California Cancer Medical CenterWest Covina, California  91790
The Cleveland Clinic FoundationCleveland, Ohio  
Kansas City Oncology and Hematology GroupKansas City, Missouri  64111
Hoag Cancer CenterNewport Beach, California  92658
Oncology Specialists, S.C.Park Ridge, Illinois  60068
ACRC/Arizona Clinical Research Center, Inc.Tucson, Arizona  85712
UC Davis Cancer CenterSacramento, California  95817
Georgetown University Medical Center, Lombardi Cancer CenterWashington, District of Columbia  20007
Division of Hematology/Oncology, University of Miami School of MedicineMiami, Florida  333136
Northwestern University, Feinberg School of MedicineChicago, Illinois  60611
Louisiana Health Sciences Center, Department of Medicine, Hematology/OncologyShreveport, Louisiana  71130
Arch Medical Group, LLCSt. Louis, Missouri  63141
Dartmouth-Hitchcock-Medical CenterLebanon, New Hampshire  03756
Our Lady of Mercy Medical Center, Comprehensive Cancer CenterBronx, New York  10466
East Carolina University School of Medicine/ Division of Hematology/OncologyGreenville, North Carolina  27858
Roger Maris Health SystemFargo, North Dakota  58122
Gabrail Cancer CenterCanton, Ohio  44718
Oncology Hematology Care Inc.Cincinnati, Ohio  45242
Hematology /Oncology Consultants Inc.Columbus, Ohio  43235
Oregon Heath and Science UniversityPortland, Oregon  97201
Germantown Cancer CenterGermantown, Tennessee  38138
Cancer Specialists of South Texas, P.A.Corpus Christi, Texas  78412
Virginia Cancer InstituteRichmond, Virginia  23230